share_log

BioNTech | 6-K: BioNTech to Present Clinical Data Updates For Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024

BioNTech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

BioNTech | 6-K:外國發行人報告
美股SEC公告 ·  03/11 09:06
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息